Immediate Stiffness Changes in Myofascial Trigger Points After Dry Needling (ELECTROP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04832074 |
|
Recruitment Status :
Completed
First Posted : April 5, 2021
Last Update Posted : February 22, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Myofascial Pain Syndrome Neck Pain Trigger Point Pain, Myofascial | Other: Dry Needling Other: Sham Dry Needling | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 60 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Randomized, Double-Blinded, Placebo-Controlled Trial |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Immediate Stiffness Changes in Upper Trapezius Active Myofascial Trigger Points After Dry Needling in Patients With Neck Pain: A Randomized, Double-Blinded, Placebo-Controlled Trial |
| Actual Study Start Date : | May 5, 2021 |
| Actual Primary Completion Date : | May 18, 2021 |
| Actual Study Completion Date : | May 19, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Dry Needling
Dry needling will be performed with 'solid filiform needles'. The procedure is as follows: The participant will lie in the prone position. The overlying skin will be cleaned with antiseptic spray. The taut band and MTrP, will be localized manually. After measuring the Pain Pressure Thresholds in this location and the control (located 3 cm lateral to the MTrP), the needle within its plastic guide tube will be placed over the MTrP. After a tapping movement to insert the needle, the needle will be moved to the muscle around the bundle and moved forward and backward to the tissue to elicit a small muscle twitch. After eliciting LTR, needling will be stopped. If no twitch were elicited, needling will stopped after two or three stellate movements |
Other: Dry Needling
Real Dry Needling in the most active Myofascial Trigger Point |
|
Sham Comparator: Sham Dry Needling
The same approach will be used with the exception of piercing the skin. The guide tube will press against the tissue and the sham needle will be allowed to drop against the skin. The handle will be tapped briskly but not breaking the skin. The sham needle will stay within the guide tube and will be pressed against the skin twice so as to mimic the quick "in and out" technique.
|
Other: Sham Dry Needling
Sham Dry Needling in the same location, but not piercing the skin |
- SWE - Young modulus [ Time Frame: Baseline ]KPa
- SWE - Young modulus [ Time Frame: 10 minutes ]KPa
- SWE - Local shear wave speed [ Time Frame: Baseline ]m/s
- SWE - Local shear wave speed [ Time Frame: 10 minutes ]m/s
- Pain Pressure Thresholds [ Time Frame: Baseline ]kg/cm2
- Pain Pressure Thresholds [ Time Frame: 10 minutes ]kg/cm2
- Visual Analogue Scale [ Time Frame: Baseline ]0-10
- Neck Disability Index [ Time Frame: Baseline ]0-100
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients between 18 and 65 and
- Presence of mechanical neck pain for at least three months duration
- Presence of at least one active MTrP in the Upper Trapezius muscle
Exclusion Criteria:
- Neck pain of traumatic origin (such as whiplash-associated disorder)
- Current use of any kind of analgesic therapy
- Presenting any condition usually considered a perpetuating factor of MTrPs, such as fibromyalgia, hypothyroidism, or iron deficiencies
- Presenting any contraindication for Dry Needling application
- Neuropathies (e.g., radiculopathy)
- Bilateral Pain
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04832074
| Spain | |
| Francisco de Vitoria University | |
| Pozuelo De Alarcón, Madrid, Spain, 28223 | |
| Principal Investigator: | Juan Antonio Valera-Calero, PhD | Camilo José Cela University |
| Responsible Party: | Camilo Jose Cela University |
| ClinicalTrials.gov Identifier: | NCT04832074 |
| Other Study ID Numbers: |
CamiloJcU21 |
| First Posted: | April 5, 2021 Key Record Dates |
| Last Update Posted: | February 22, 2022 |
| Last Verified: | May 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Myofascial Pain Syndromes Fibromyalgia Neck Pain Pain Neurologic Manifestations |
Muscular Diseases Musculoskeletal Diseases Rheumatic Diseases Neuromuscular Diseases Nervous System Diseases |

